EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
-15.59%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$869M
AUM Growth
+$869M
(-10%)
Cap. Flow
+$137M
Cap. Flow
% of AUM
15.76%
Top 10 Holdings %
Top 10 Hldgs %
61.15%
Holding
62
New
17
Increased
11
Reduced
13
Closed
12
Top Buys
| 1 |
argenx
ARGX
|
$79.3M |
| 2 |
Xencor
XNCR
|
$35.8M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$35.3M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$27.5M |
| 5 |
Solid Biosciences
SLDB
|
$23.2M |
Top Sells
| 1 |
MacroGenics
MGNX
|
$31.8M |
| 2 |
Ascendis Pharma
ASND
|
$25.5M |
| 3 |
FibroGen
FGEN
|
$22.8M |
| 4 |
Scholar Rock
SRRK
|
$20.5M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$19.4M |
Sector Composition
| 1 | Healthcare | 89.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
argenx
ARGX
$43.6B
| $79.3M | 7.93% | +825,087 | New | +$79.3M |
|
2
Kura Oncology
KURA
$686M
| $74.1M | 7.41% | 5,276,753 +1,373,778 | +35% | +$19.3M |
|
|
3
FibroGen
FGEN
$47.8M
| $70.6M | 7.06% | 1,524,557 -492,693 | -24% | -$22.8M |
|
4
Ironwood Pharmaceuticals
IRWD
$214M
| $55.8M | 5.58% | 5,381,282 +239,658 | +5% | +$2.48M |
|
5
Assembly Biosciences
ASMB
$190M
| $54.4M | 5.44% | 2,404,853 -538,311 | -18% | -$12.2M |
|
|
ONCE
6
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $44.5M | 4.45% | 1,136,851 +299,803 | +36% | +$11.7M |
|
|
7
Ascendis Pharma
ASND
$11.8B
| $42.6M | 4.26% | 679,746 -407,511 | -37% | -$25.5M |
|
|
8
Ionis Pharmaceuticals
IONS
$6.79B
| $39.2M | 3.92% | 725,326 +653,000 | +903% | +$35.3M |
|
|
9
Xencor
XNCR
$580M
| $35.8M | 3.58% | +989,018 | New | +$35.8M |
|
|
DRNA
10
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $35.5M | 3.55% | 3,316,407 -485,920 | -13% | -$5.19M |
|
|
11
Scholar Rock
SRRK
$3.14B
| $33.9M | 3.39% | 1,474,228 -893,150 | -38% | -$20.5M |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $27.5M | 2.75% | +647,169 | New | +$27.5M |
|
13
Kezar Life Sciences
KZR
$28.9M
| $25M | 2.5% | 1,060,018 -228,180 | -18% | -$5.38M |
|
|
14
Solid Biosciences
SLDB
$427M
| $23.2M | 2.33% | +867,246 | New | +$23.2M |
|
|
AKCA
15
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $19.3M | 1.93% | 639,743 -115,377 | -15% | -$3.48M |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $16.2M | 1.62% | 1,595,643 +556,143 | +54% | +$5.65M |
|
|
UBX
17
DELISTED
Unity Biotechnology
UBX
| $15.7M | 1.57% | 967,114 | – | – |
|
18
Sangamo Therapeutics
SGMO
$157M
| $13.6M | 1.36% | 1,185,831 +842,600 | +245% | +$9.67M |
|
19
Zai Lab
ZLAB
$3.68B
| $13.2M | 1.32% | 569,377 +219,377 | +63% | +$5.09M |
|
20
Arcus Biosciences
RCUS
$1.13B
| $13.2M | 1.32% | 1,223,495 -1,012,892 | -45% | -$10.9M |
|
21
Arbutus Biopharma
ABUS
$711M
| $12.6M | 1.26% | 3,281,502 +2,049,702 | +166% | +$7.85M |
|
|
MYOK
22
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $11.5M | 1.15% | +234,381 | New | +$11.5M |
|
23
Rhythm Pharmaceuticals
RYTM
$6.85B
| $10.8M | 1.08% | +400,838 | New | +$10.8M |
|
24
Wave Life Sciences
WVE
$1.53B
| $9.84M | 0.98% | 233,933 +189,092 | +422% | +$7.95M |
|
|
SURF
25
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $9.59M | 0.96% | 2,261,328 +897,849 | +66% | +$3.81M |
|